1. Pharmacology of risperidone (R64766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.;Jansen;J Pharmacol Exp Ther,1988
2. Risperidone versus haloperidol in the treatment of chromic schizophrenia inpatients: multicenter double-blind comparative study.;Claus;Acta Psychiatr Scand,1992
3. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenia patients published correction appears in J Clin Psychopharmacol 1993;13:149.;Chouinard;J Clin Psychopharmacol,1993
4. Absorption, metabolism, and excretion of risperidone in humans.;Mannens;Drug Metab Dispos,1993
5. Metabolism of risperidone to 9-hydroxy-risperidone by human cytochromes P450 2D6 and 3A4.;Fang;Naunyn Schmiedebergs Arch Pharmacol,1999